Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis

@article{Myerson2011ThrombininhibitingPN,
  title={Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis},
  author={J. Myerson and L. He and G. Lanza and D. Tollefsen and S. Wickline},
  journal={Journal of Thrombosis and Haemostasis},
  year={2011},
  volume={9}
}
  • J. Myerson, L. He, +2 authors S. Wickline
  • Published 2011
  • Chemistry, Medicine
  • Journal of Thrombosis and Haemostasis
  • Summary.  Background: As a regulator of the penultimate step in the coagulation cascade, thrombin represents a principal target of direct and specific anticoagulants. Objective: A potent thrombin inhibitor complexed with a colloidal nanoparticle was devised as a first‐in‐class anticoagulant with prolonged and highly localized therapeutic impact conferred by its multivalent thrombin‐absorbing particle surface. Methods: PPACK (Phe[D]‐Pro‐Arg‐Chloromethylketone) was secured covalently to the… CONTINUE READING
    71 Citations
    Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
    • 5
    • Highly Influenced
    An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    • Y. Huang, L. Yu, +6 authors Rongjun Chen
    • Chemistry, Medicine
    • Journal of controlled release : official journal of the Controlled Release Society
    • 2019
    • 13
    • PDF
    Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis
    • 22
    • Highly Influenced
    Inhibition of thrombin by functionalized C60 nanoparticles revealed via in vitro assays and in silico studies.
    • 3
    Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.
    • 20

    References

    SHOWING 1-10 OF 40 REFERENCES
    Progress in the design of low molecular weight thrombin inhibitors
    • 43
    Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
    • S. Flaim
    • Chemistry, Medicine
    • Artificial cells, blood substitutes, and immobilization biotechnology
    • 1994
    • 138
    Targeting atherosclerosis by using modular, multifunctional micelles
    • 203
    • PDF
    An overview of the structure and function of thrombin.
    • 190